上海招聘Immunization and Hybridoma Associate Scientist

Immunization and Hybridoma Associate Scientist

和铂医药（上海）有限责任公司

公司规模：150-500人
公司性质：外资（欧美）
公司行业：制药/生物工程

职位信息

发布日期：2019-11-14
工作地点：上海-浦东新区
招聘人数：若干人
工作经验：无工作经验
学历要求：招若干人
语言要求：不限
职位月薪：1-2万/月
职位类别：医药技术研发人员

职位描述

1. Responsible for antibody lead generation to support biological therapeutics programs and early target discovery efforts across multiple disease areas.

2. Design and execute antibody discovery projects, including designing immunization strategies against difficult targets, designing protein and cell-based assays for binding and functional activity selection of target-specific antibody candidates.

3. Maintain an up-to-date laboratory notebook that records experimental methods, materials and results. Keep supervisor and project team informed on current status of work. Prepare presentations to show work being conducted on project or group meetings. Prepare manuscripts and documents for internal or external publication. Training other laboratory personnel on experimental SOP.

职位要求：

Academic / Professional qualification

· Bachelor or Master degree on medical, pharmacy, pharmacology, biochemistry or chemistry

- Technical / skills training

· Expertise in immunization strategies.

· Experience in monoclonal antibody generation from immunized sources, including hybridoma generation,

· Expertise in designing and executing immunological methods such as ELISA, FACS, Western, ForteBio Octet and cell-based assays.

· Familiarity with antibody properties and sequences.

· Broad experience in cell biology, including mammalian cell culture, cell transfection, and protein expression.

· Good project management skill and experience.

- Working experience

Prior industry experience is a strong plus, minimum 3-year working experiences in antibody discovery of pharmaceutical company.

职能类别：医药技术研发人员

关键字：Hybridoma technology

公司介绍

和铂医药是一家专注于肿瘤免疫领域创新药物研究与开发的全球化运营生物医药公司。公司将运用其拥有的全部自主知识产权的全人源单抗的转基因鼠系列核心技术平台，建立下一代治疗性肿瘤抗体药物产品管线,并将围绕Harbour的两大平台拓展合作与授权业务。公司总部及研发基地位于中国上海，另外在美国马塞诸塞州剑桥设立商业运营中心，在荷兰鹿特丹设立抗体研发平台创新中心，在波士顿地区设立了创新中心包括实验室和研发团队，也将在江苏昆山设立研发基地。公司拥有资深管理团队以及丰富的药物研究与开发经验。和铂医药要为满足中国及全球病人的需求而不断努力，依托拥有自主知识产权的核心技术平台,创建一个在肿瘤治疗领域有科学与技术领导力的国际性生物医药公司。同时, 在药物研发领域建立以技术平台为基础的对外合作，整合新的技术，推动中国整个抗体研发产业的进步。

Company Overview
Harbour BioMed is a global biotechnology company discovering and developing innovative therapeutics for cancer with a focus on immuno-oncology and autoimmunity/inflammation. The company's discovery and development programs are centered around its two patented transgenic mouse platforms for human antibody discovery.
The company is building its proprietary pipeline internally, through collaborations with co-development partners, as well as through selective preclinical and clinical stage asset acquisitions. Harbour BioMed also licenses the platforms to companies and academic institutions through its Harbour Antibodies subsidiary.
Harbour BioMed has headquarters and an R&D site in Shanghai, business operations in Cambridge, MA, and antibody platform development in Rotterdam, The Netherlands.
The company has an innovation center including research lab and a development team in Boston. Also, we are expanding to Kunshan site in Jiangsu for our R&D operation.

联系方式